Back
C.H. Robinson Worldwide Vs. Aligos Therapeutics Industry Stock Comparison
Buy
53
CHRW
C.H. Robinson Worldwide
Last Price:
$104.33
Seasonality Move:
2.25%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$43.62
Seasonality Move:
7.18%
Buy
53
C.H. Robinson Worldwide (CHRW)
is a Buy
Is C.H. Robinson Worldwide a Buy, Sell or Hold?
-
The current C.H. Robinson Worldwide [CHRW] share price is $104.32. The Score for CHRW is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
CHRW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHRW Stock Price Chart
What is C.H. Robinson Worldwide's stock price today?
-
The C.H. Robinson Worldwide share price today is $104.32Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHRW is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CHRW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 40.6 | Sell |
| Chaikin Money Flow: | 249999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.9 - 109.68) | Sell |
| Bollinger Bands (100): | (101.47 - 109.41) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.71 | Buy |
| Relative Strength Index (14 RSI): | 81.52 | Buy |
| Chaikin Money Flow: | 630913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.74 - 36.8) | Buy |
| Bollinger Bands (100): | (6.83 - 25.23) | Buy |
CHRW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.92 | Sell |
| 20-day SMA: | 107.16 | Sell |
| 50-day SMA: | 107.68 | Sell |
| 200-day SMA: | 93.39 | Buy |
| 8-day EMA: | 105.63 | Sell |
| 20-day EMA: | 106.87 | Sell |
| 50-day EMA: | 106.77 | Sell |
| 200-day EMA: | 98.03 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.61 | Buy |
| 20-day SMA: | 32.22 | Buy |
| 50-day SMA: | 20.6 | Buy |
| 200-day SMA: | 16.51 | Buy |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 32.66 | Buy |
| 50-day EMA: | 24.43 | Buy |
| 200-day EMA: | 18.11 | Buy |
C.H. Robinson Worldwide Earnings Growth & CHRW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.53 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
C.H. Robinson Worldwide Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||